Cancer Research Cancer Epigenetics  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 5349-5355, October 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Folger, P. A.
Right arrow Articles by Pardee, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Folger, P. A.
Right arrow Articles by Pardee, J. D.
[Cancer Research 59, 5349-5355, October 15, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

A Mammalian Severin Replaces Gelsolin in Transformed Epithelial Cells1

Paula A. Folger2, William J. Berg, Zoraida DeJesus, Yuman Fong and Joel D. Pardee3

Department of Cell Biology and Anatomy, Joan and Sanford I. Weill Medical College and Graduate School of Medical Sciences of Cornell University, New York, New York 10021 [P. A. F., Z. D., J. D. P.], and Departments of Surgery [Y. F.] and Medicine [W. J. B.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021

A persisting paradox in cytoskeletal regulation of cell motility is the loss of the actin filament fragmenting protein, gelsolin, in transformed epithelial cells that have gained the ability to migrate. Either actin filament severing does not occur during motility of carcinoma cells or a novel fragmentation protein is expressed during transformation. Using an antibody specific for severin, the Mr 40,000 actin filament severing protein from Dictyostelium discoideum amoebae, we have identified a mammalian form of severin in murine LL/2 carcinoma cells lacking gelsolin. Mammalian severin (M-severin) isolated from LL/2-derived Lewis lung carcinoma tumors severed F-actin in a calcium-dependent manner, mimicking the function of Dictyostelium severin. M-severin preferentially localized to the cleavage furrow of dividing LL/2 cells and to the actin-rich cortex of migratory LL/2 cells, known sites of active actin cytoskeleton rearrangement. The mammalian severing protein was fully expressed in transformed LL/2 epithelial cells but went undetected in normal mouse muscle, liver, spleen, or kidney. Normal mouse lung tissue contained minute amounts of M-severin, attributed to motile cells in pulmonary connective tissue. In striking contrast to M-severin, gelsolin was highly expressed in normal lung but disappeared in transformed LL/2 carcinoma cells. Based on prior observations of a functional role for actin filament fragmentation in cell migration, the simultaneous induction of M-severin and loss of gelsolin during epithelial transformation suggests that replacement of gelsolin by M-severin may function to achieve actin filament rearrangements necessary for active cell migration in invasive or metastatic carcinoma. Induction of M-severin in an invasive tumor was directly observed in human colon adenocarcinoma by cytoimmunohistochemistry with antibodies directed against severin isolated from both Dictyostelium amoebae and Lewis lung carcinoma cells. Because normal colon epithelium from the same patient did not express M-severin, it may serve as a sensitive marker for detection and staging of epithelial tumors.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Tomar, S. George, P. Kansal, Y. Wang, and S. Khurana
Interaction of Phospholipase C-{gamma}1 with Villin Regulates Epithelial Cell Migration
J. Biol. Chem., October 20, 2006; 281(42): 31972 - 31986.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
X. Fan, J. Hou, X. Chen, F. Chaudhry, C. J. Staiger, and H. Ren
Identification and Characterization of a Ca2+-Dependent Actin Filament-Severing Protein from Lily Pollen
Plant Physiology, December 1, 2004; 136(4): 3979 - 3989.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Soriano and J. D. Pardee
M34 Actin Regulatory Protein Is a Sensitive Diagnostic Marker for Early- and Late-Stage Mammary Carcinomas
Clin. Cancer Res., July 1, 2004; 10(13): 4437 - 4443.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Sung, W. Luo, D. Qian, I. Lee, B. Jallal, and M. Gishizky
The Ste20 Kinase MST4 Plays a Role in Prostate Cancer Progression
Cancer Res., June 15, 2003; 63(12): 3356 - 3363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.